Day: September 19, 2022

health news

GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)

Staff September 19, 2022

Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization...

Read MoreRead more about GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)
health news

AXIM® Biotechnologies Signs Exclusive Global Commercialization Agreement With Verséa™ Ophthalmics for Distribution and Sales of Novel Ophthalmic Diagnostics Solutions

Staff September 19, 2022

Under the Agreement the Company will Sell and Distribute Globally AXIM’s Readers and Three Novel Proprietary Tests Designed for Diagnosis...

Read MoreRead more about AXIM® Biotechnologies Signs Exclusive Global Commercialization Agreement With Verséa™ Ophthalmics for Distribution and Sales of Novel Ophthalmic Diagnostics Solutions

You may have missed

health news

The Pause Technologies Completes Participation in 2025 Mayo Clinic and ASU MedTech Accelerator

Staff April 3, 2025
health news

HiTouch, a Mobile App that Improves the Happiness of Individuals and Organizations

Staff April 3, 2025
health news

PreveCeutical Announces Update to Non-Brokered Private Placement

Staff April 2, 2025
health news

Lam Research Corporation Announces March Quarter Financial Conference Call

Staff April 2, 2025
health news

Former Pfizer R&D Chief Mikael Dolsten Joins Formation Bio to Chair Drug Picking Committee and Co-Chair its Investment Advisory Committee

Staff April 2, 2025
error: Content is protected !!